NL
DE
18 June 2018
Research project: Focus on values to stimulate shared decisions in patients with thyroid cancer: A multifaceted COMmunication BOoster (COMBO).
Peep Stalmeier, theme Womens's cancers, RIHS
Approved budget: € 508,428
Research project: Phase IIa study of ex vivo-generated allogeneic NK cell infusion in combination with subcutaneous IL-15 superagonist ALT-803 in relapsed/refractory AML patients.
Harry Dolstra, theme Cancer development and immune defense, RIMLS
Approved budget: € 1,294,415
Research project: Galactin-9 is required for Dendritic Cell function during anti-melanoma immunity.
Annemiek van Spriel, theme Cancer development and immune defense, RIMLS
Approved budget: € 623,515
Research project: FORwards: Feasibility and effectiveness Of Real-world use of the SWORD evidence-based
psychological intervention for fear of cancer recurrence.
Judith Prins, theme Women's cancers, RIHS
Approved budget: € 453,919
Research project: Understanding brain mechanisms of cancer-related fatigue: a sickness-behaviour approach.
Marieke van der Schaaf, theme Stress related disorders, DCMN
Approved budget: € 632,612
Research project: The cell by cell measuring of the response to therapy to detect resistant cells.
Klaas Mulder, theme Cancer development and immune defense, RIMLS
Approved budget: € 220,646
Research project: STOPOVCA: STOP OVarian CAncer: the implementation of opportunistic salpingectomy to prevent ovarian cancer.
Joanne de Hullu, theme Women's cancers, RIHS
Approved budget: € 416,684
Research project: ImplemenTation of concentration gUided dosing to optimize treatmeNt outcomE in patients treated with oral targeted anticancer drugs (TUNE project).
Ingrid Desar, theme Rare cancers, RIHS
Approved budget: € 683,113
Go to the Dutch Cancer Society website (KWF).
The Dutch Cancer Society (KWF) has awarded 8 grants to Radboudumc researchers. We congratulate them with this funding and wish them success with their great work.
Research projects:
Research project: Focus on values to stimulate shared decisions in patients with thyroid cancer: A multifaceted COMmunication BOoster (COMBO).
Peep Stalmeier, theme Womens's cancers, RIHS
Approved budget: € 508,428
Research project: Phase IIa study of ex vivo-generated allogeneic NK cell infusion in combination with subcutaneous IL-15 superagonist ALT-803 in relapsed/refractory AML patients.
Harry Dolstra, theme Cancer development and immune defense, RIMLS
Approved budget: € 1,294,415
Research project: Galactin-9 is required for Dendritic Cell function during anti-melanoma immunity.
Annemiek van Spriel, theme Cancer development and immune defense, RIMLS
Approved budget: € 623,515
Research project: FORwards: Feasibility and effectiveness Of Real-world use of the SWORD evidence-based
psychological intervention for fear of cancer recurrence.
Judith Prins, theme Women's cancers, RIHS
Approved budget: € 453,919
Young Investigator grant:
Research project: Understanding brain mechanisms of cancer-related fatigue: a sickness-behaviour approach.
Marieke van der Schaaf, theme Stress related disorders, DCMN
Approved budget: € 632,612
Unique high risk project:
Research project: The cell by cell measuring of the response to therapy to detect resistant cells.
Klaas Mulder, theme Cancer development and immune defense, RIMLS
Approved budget: € 220,646
Implementation project
Research project: STOPOVCA: STOP OVarian CAncer: the implementation of opportunistic salpingectomy to prevent ovarian cancer.
Joanne de Hullu, theme Women's cancers, RIHS
Approved budget: € 416,684
Research project: ImplemenTation of concentration gUided dosing to optimize treatmeNt outcomE in patients treated with oral targeted anticancer drugs (TUNE project).
Ingrid Desar, theme Rare cancers, RIHS
Approved budget: € 683,113
Go to the Dutch Cancer Society website (KWF).
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
KWF Roadshow 11 November 2019
10 October 2019 In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field. read more
Awarded KWF grants for Radboudumc researchers
2 July 2019 The Dutch Cancer Society (KWF) has awarded 25.5 million euros to 50 new research projects in 16 different institutes. 8 grants are awarded to Radboudumc researchers. We congratulate our researchers with this funding and wish them success with their great work. read more
Internal KWF review procedure 2020
13 June 2019 In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read moreInternal KWF review procedure 2019
4 April 2019 In agreement with the existing policy the research board and Radboudumc Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read moreInternal KWF review procedure 2019
19 December 2018 In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more